Literature DB >> 33090248

Potential Benefits of Holmium-166 Radioembolization as a Neoadjuvant Treatment of Intrahepatic Cholangiocarcinoma.

Tommaso Depalo1, Giuseppe Boni2, Davide Ghinolfi3, Elena Bozzi4, Rosa Cervelli4, Gabriele Catalano3, Duccio Volterrani2, Irene Bargellini4.   

Abstract

Entities:  

Year:  2020        PMID： 33090248     DOI： 10.1007/s00270-020-02607-1

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN： 0174-1551            Impact factor:   2.740


× No keyword cloud information.
  4 in total

Review 1.  Radioembolization of Intrahepatic Cholangiocarcinoma: Patient Selection, Outcomes, and Competing Therapies.

Authors:  Joseph Ray Ness; Christopher Molvar
Journal:  Semin Intervent Radiol       Date:  2021-10-07       Impact factor: 1.780

2.  Spontaneous Haematomas in Anticoagulated Covid-19 Patients: Diagnosis and Treatment by Embolization.

Authors:  Lorena López-Martínez; Juan D Molina-Nuevo; María J Pedrosa-Jiménez; Enrique Juliá-Mollá
Journal:  Cardiovasc Intervent Radiol       Date:  2022-01-28       Impact factor: 2.740

Review 3.  SIRT in 2025.

Authors:  Francesca Romana Ponziani; Francesco Santopaolo; Antonio Gasbarrini; Roberto Iezzi; Alessandro Posa; Maurizio Pompili; Alessandro Tanzilli; Marta Maestri; Maria Pallozzi; Francesca Ibba; Riccardo Manfredi
Journal:  Cardiovasc Intervent Radiol       Date:  2022-08-08       Impact factor: 2.797

4.  Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT).

Authors:  Thomas Helmberger; Rita Golfieri; Maciej Pech; Thomas Pfammatter; Dirk Arnold; Roberto Cianni; Geert Maleux; Graham Munneke; Olivier Pellerin; Bora Peynircioglu; Bruno Sangro; Niklaus Schaefer; Niels de Jong; José Ignacio Bilbao
Journal:  Cardiovasc Intervent Radiol       Date:  2020-09-21       Impact factor: 2.740
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.